Skip to main content
Top
Published in: Advances in Therapy 2/2006

01-03-2006

Neuraminidase decreases in vitro adherence of slime-forming coagulase-negative staphylococci to biosynthetic ovine collagen vascular graft

Authors: Gokhan Onem, MD, Mustafa Sacar, MD, Suzan Sacar, MD, Serhan Sakarya, MD, Huseyin Turgut, MD, Ali Vefa Ozcan, MD, Ahmet Baltalarli, MD

Published in: Advances in Therapy | Issue 2/2006

Login to get access
Metadata
Title
Neuraminidase decreases in vitro adherence of slime-forming coagulase-negative staphylococci to biosynthetic ovine collagen vascular graft
Authors
Gokhan Onem, MD
Mustafa Sacar, MD
Suzan Sacar, MD
Serhan Sakarya, MD
Huseyin Turgut, MD
Ali Vefa Ozcan, MD
Ahmet Baltalarli, MD
Publication date
01-03-2006
Publisher
Springer Healthcare Communications
Published in
Advances in Therapy / Issue 2/2006
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/BF02850131

Other articles of this Issue 2/2006

Advances in Therapy 2/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine